Will lithium damage my kidneys?

Journal of Psychiatry and Neuroscience

Volumn 37, Issue 3, 2012, Pages E5-

  Raedler, Thomas J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 2; CREATININE; LITHIUM; VALPROATE SEMISODIUM;

ACUTE DISEASE; ADULT; ANXIETY; ARTICLE; BIPOLAR MANIA; CASE REPORT; CREATININE BLOOD LEVEL; DEPRESSION; DRUG ACCUMULATION; DRUG WITHDRAWAL; FIBROSING ALVEOLITIS; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; HYPOMANIA; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NEPHROGENIC DIABETES INSIPIDUS; NEPHROTOXICITY; POLYDIPSIA; POLYURIA; PSYCHOPHARMACOLOGY; SUICIDAL BEHAVIOR;

EID: 84860517777     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.110186     Document Type: Article

References (16)

1. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and Inter -national Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009;11:225-255.
2. Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 2011;378:1306-1315.
3. Geddes JR, Burgess S, Hawton K, et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004;161:217-222.
4. Schou M. Forty years of lithium treatment. Arch Gen Psychiatry 1997;54:9-13.
5. Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005;162:1805-1819.
6. Yildiz A, Vieta E, Leucht S, et al. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology 2011; 36: 375-389.
7. Bendz H, Aurell M. Drug-induced diabetes insipidus: incidence, prevention and management. Drug Saf 1999;21:449-456.
8. Bendz H, Aurell M, Balldin J, et al. Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant 1994;9:1250-1254.
9. Lepkifker E, Sverdlik A, Iancu I, et al. Renal insufficiency in long-term lithium treatment. J Clin Psychiatry 2004;65:850-856.
10. Bendz H, Schon S, Attman PO, et al. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 2010; 77:219-224.
11. Presne C, Fakhouri F, Noel LH, et al. Lithium-induced nephropathy: rate of progression and prognostic factors. Kidney Int 2003;64:585-592.
12. Markowitz GS, Radhakrishnan J, Kambham N, et al. Lithium nephrotoxi-city: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 2000;11:1439-1448.
13. Grünfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol 2009;5:270-276.
14. Raedler TJ, Wiedemann K. Lithium-induced nephropathies. Psychopharmacol Bull 2007; 40:134-149.
15. Kripalani M, Shawcross J, Reilly J, et al. Lithium and chronic kidney disease. BMJ 2009;339:b2452.
16. Grof P, Duffy A, Alda M, et al. Lithium response across generations. Acta Psychiatr Scand 2009;120:378-385.